GNCA News and Press, Genocea Biosciences Inc.

Genocea Biosciences Inc Ordinary Shares (GNCA) is expected to report for Q4 2022

=Gainers: BlackSky Technology (BKSY) +93%. StoneMor (STON) +51%. Genocea Biosciences (GNCA) +35%. Hoegh LNG Partners (HMLP) +31%. Caleres (CAL) +27%. Evelo Biosciences (EVLO) +20%. Spire Global (SPIR) +17%. Groupon (GRPN) +17%. Abercrombie & Fitch (ANF) +17%. Losers: Verrica Pharmaceutica...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Happiness Development (NASDAQ: HAPP ) is expanding EV development. It also announced a deal for up to 2,000 EVs. That deal could generate up to $30 million for the company. Source: Shutterstock Happines...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Genocea Biosciences (NASDAQ: GNCA ) is closing down its business. It’s terminating all employees not needed to shut the company down. This also has it delisting shares of GNCA stock. Source: arfa adam...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Motus GI (NASDAQ: MOTS ) stock is our biggest winner this morning. Verrica Pharmaceuticals (NASDAQ: VRCA ) shares lead our losers today. Wendy’s (NASDAQ: WEN ) is rising on acquisition talks. ...

Genocea Biosciences (NASDAQ:GNCA) said its board voted to wind down the company's ongoing operations and terminate the remaining employees except those necessary to complete an orderly wind down. In April, Cambridge, Mass.-based company said it reducing its workforce by ~65% and explorin...

CAMBRIDGE, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that its Board of Directors voted to wind down the Company’s ongoing operations and terminate the ...

Genocea Biosciences (NASDAQ:GNCA) has initiated a process to explore a range of strategic alternatives to maximize shareholder value, including the sale of all or part of the company, merger or reverse merger. The company has engaged professional advisors, including an investment bank to act ...

CAMBRIDGE, Mass., April 28, 2022 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today announced that it has initiated a process to explore a range of strategic alternatives to maximize sharehol...

What to Know About Trading Penny Stocks on April 11th With another week of trading penny stocks getting off to an interesting start, there is a lot for investors to know. Considering that there is still an extremely high amount of volatility in the stock market, investors need to be on ...